<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In thromboembolic <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarctions</z:e> high fibrinogen levels are associated with an increase of both plasma and whole blood viscosity as well as increased aggregability of blood cells </plain></SENT>
<SENT sid="1" pm="."><plain>This decreases cerebral perfusion and might reduce blood flow in the penumbra surrounding infarction </plain></SENT>
<SENT sid="2" pm="."><plain>An important goal in the treatment of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> is to reduce fibrinogen and thereby improve the haemorheological state </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="5" ids="28304">Heparin</z:chebi>-induced extracorporeal <z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi>/fibrinogen precipitation (HELP) appears to be successful in achieving this </plain></SENT>
<SENT sid="4" pm="."><plain>Such treatment reduces <z:chebi fb="23" ids="18059">lipid</z:chebi> fractions, including total cholesterol, <z:chebi fb="2" ids="39026">low-density lipoproteins</z:chebi> (<z:chebi fb="15" ids="39026">LDL</z:chebi>) and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (p &lt; 0.0001 each), as well as fibrinogen (p &lt; 0.0001) in a safe and efficacious manner </plain></SENT>
<SENT sid="5" pm="."><plain>Whole blood and plasma viscosity are also improved when measured by oscillo-rheometry </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, the number and aggregation tendency of blood cells is influenced positively as determined by Coulter counting and aggregometry </plain></SENT>
<SENT sid="7" pm="."><plain>HELP improves the haemorheological profile to a degree which has not been achieved by haemorheologically active substances </plain></SENT>
</text></document>